Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$652M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$518M |
| 3 |
iShares MBS ETF
MBB
|
+$406M |
| 4 |
Procter & Gamble
PG
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$642M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$570M |
| 3 |
Sempra
SRE
|
+$490M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| 1 | Technology | 17.54% |
| 2 | Healthcare | 11.42% |
| 3 | Financials | 10.41% |
| 4 | Consumer Discretionary | 9.33% |
| 5 | Communication Services | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Omeros
OMER
$278M
| $691K | ﹤0.01% |
49,059
-45,511
| -48% | -$641K |
|
2452
BioCryst Pharmaceuticals
BCRX
$1.62B
| $688K | ﹤0.01% |
199,404
-33,802
| -14% | -$117K |
|
2453
Opko Health
OPK
$1.1B
| $688K | ﹤0.01% |
467,559
+168,906
| +57% | +$249K |
|
|
NS
2454
DELISTED
NuStar Energy L.P.
NS
| $687K | ﹤0.01% |
26,557
+8,183
| +45% | +$212K |
|
|
FSB
2455
DELISTED
Franklin Financial Network, Inc.
FSB
| $686K | ﹤0.01% |
19,966
+6,915
| +53% | +$238K |
|
|
QD
2456
Qudian
QD
$720M
| $685K | ﹤0.01% |
145,426
-675,213
| -82% | -$3.18M |
|
2457
First Foundation Inc
FFWM
$489M
| $680K | ﹤0.01% |
39,106
+19,792
| +102% | +$344K |
|
2458
Quince Therapeutics
QNCX
$85.9M
| $680K | ﹤0.01% |
12,113
+10,539
| +670% | +$592K |
|
2459
Amneal Pharmaceuticals
AMRX
$3.07B
| $676K | ﹤0.01% |
140,144
+72,051
| +106% | +$348K |
|
2460
National Presto Industries
NPK
$818M
| $676K | ﹤0.01% |
7,642
+489
| +7% | +$43.3K |
|
|
HAYN
2461
DELISTED
Haynes International, Inc.
HAYN
| $676K | ﹤0.01% |
18,892
+6,453
| +52% | +$231K |
|
|
NWLI
2462
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $676K | ﹤0.01% |
2,325
+1,162
| +100% | +$338K |
|
2463
PC Connection
CNXN
$1.61B
| $674K | ﹤0.01% |
13,577
+5,787
| +74% | +$287K |
|
2464
Evolent Health
EVH
$1,000M
| $674K | ﹤0.01% |
74,576
-46,400
| -38% | -$419K |
|
2465
FB Financial Corp
FBK
$2.83B
| $674K | ﹤0.01% |
17,019
+8,272
| +95% | +$328K |
|
2466
Hawkins
HWKN
$3.64B
| $672K | ﹤0.01% |
29,296
+10,060
| +52% | +$231K |
|
|
GOOD
2467
Gladstone Commercial Corp
GOOD
$606M
| $671K | ﹤0.01% |
30,705
+15,085
| +97% | +$330K |
|
2468
nLIGHT
LASR
$1.48B
| $670K | ﹤0.01% |
33,062
+16,771
| +103% | +$340K |
|
2469
Clarivate
CLVT
$2.8B
| $668K | ﹤0.01% |
39,744
+38,070
| +2,274% | +$640K |
|
2470
Intellia Therapeutics
NTLA
$1.24B
| $668K | ﹤0.01% |
45,527
+25,989
| +133% | +$381K |
|
2471
Gorman-Rupp
GRC
$1.14B
| $667K | ﹤0.01% |
17,762
+7,906
| +80% | +$297K |
|
|
ENFC
2472
DELISTED
Entegra Financial Corp.
ENFC
| $667K | ﹤0.01% |
22,094
+18,701
| +551% | +$565K |
|
|
BGG
2473
DELISTED
Briggs & Stratton Corp.
BGG
| $665K | ﹤0.01% |
99,844
+47,171
| +90% | +$314K |
|
2474
Collegium Pharmaceutical
COLL
$1.1B
| $662K | ﹤0.01% |
32,161
+7,753
| +32% | +$160K |
|
2475
Powell Industries
POWL
$3.65B
| $661K | ﹤0.01% |
13,500
+3,610
| +37% | +$177K |
|